US OptionsDetailed Quotes

ATRA240517C500

Watchlist

0.05
0.000.00%

15min DelayClose May 17 15:32 ET

0.00High0.00Low

Atara Biotherapeutics Stock Discussion

Jaguar8

May 20 08:36

$Atara Biotherapeutics(ATRA.US)$
NEWS
Atara Biotherapeutics Submits Tabelecleucel (Tab-cel®) Biologics License Application for Treatment of Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease with U.S. FDA
05/20/2024 - 06:25 AM First Allogeneic T-Cell Therapy BLA Submission to U.S. Food and Drug Administration If Approved, Tab-cel Would be First Approved Therapy in U.S. for EBV+ PTLD Acceptance of BLA Will Trigger $20 Million Milestone Payment from Pierre Fabre Laboratories, ...

joeyboulevard

May 7 11:50

$Atara Biotherapeutics (ATRA.US)$ looks like in buy range

Sean Parker

Apr 29 09:46

looks like a good day

$Atara Biotherapeutics(ATRA.US)$

Trytosaveabit

Apr 4 17:58

Im just adding a heads up to my previous post about upcoming BLA submission!

$Atara Biotherapeutics(ATRA.US)$ PAY VERY CLOSE ATTENTION TO THE LAST 3 BULLET POINTS! This could be a catalyst for a large price increase? Even if its only a temporary increase? I want you to have ample opportunity to catch ahead of time if YOU CHOOSE? Not me choosing for YOU! NFA! Just a heads up for the possibility! Tab-cel U.S. BLA on Track for Submission in Q2 2024 Following Positive Pre-BLA Me...

Trytosaveabit

Mar 29 15:12

Pay attention to the dates! Make a note !

$Atara Biotherapeutics(ATRA.US)$ Tab-cel U.S. BLA on Track for Submission in Q2 2024 Following Positive Pre-BLA Meeting
Allogeneic CAR T Pipeline Expands Into Autoimmune Disease With Plans To Initiate a ATA3219 Lupus Nephritis Study in H2 2024, and Initial Clinical Data Expected H1 2025
ATA3219 NHL Study Enrolling With Initial Clinical Data Expected in Q4 2024
Cash Runway Into 2027 Enables Key Pipeline Readouts

Trytosaveabit

Mar 18 15:27

New 13G! Did he get tired of naked SS? Hehehe

$Atara Biotherapeutics(ATRA.US)$ Atara Biotherapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Citadel Advisors LLC(6.4%),Citadel Advisors Holdings LP(6.4%), etc.
SEC announcement· 4 mins ago

Trytosaveabit

Feb 29 08:15

News

$Atara Biotherapeutics(ATRA.US)$ Atara Biotherapeutics Receives FDA Clearance Of IND Application In Lupus Nephritis For ATA3219
Moomoo 24/7· 1 min ago

Trytosaveabit

Feb 14 17:12

13G

$Atara Biotherapeutics(ATRA.US)$ Atara Biotherapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Redmile Group, LLC(9.9%),Jeremy C. Green(9.9%)
SEC announcement· 16:29

Trytosaveabit

Feb 14 15:04

Update

$Atara Biotherapeutics(ATRA.US)$ Atara Biotherapeutics Submits New Drug Application to FDA for ATA3219 to Treat Lupus Nephritis
MT Newswires· 4 mins ago
Atara Biotherapeutics (ATRA) said Wednesday it submitted an investigational new drug application to the US Food and Drug Administration seeking approval for ATA3219 as a standalone treatment for systemic lupus erythematosus, or lupus nephritis that affects the kidneys.
ATA3219 is an allogeneic chimeric antigen receptor T-cell therapy that ...

Trytosaveabit

Feb 13 16:10

News 13G

$Atara Biotherapeutics(ATRA.US)$ Atara Biotherapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(6.56%)
SEC announcement· 7 mins ago

No comment yet